Work

A phase I‐ II clinical trial of the anti‐ CD 74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach

Year: 2017

Type: article

Abstract: A patient based approach

Source: British Journal of Haematology

DOI: 10.1111/bjh.14726

Authors: Michal Haran, Vita Mirkin, Andrei Braester, Nurith Harpaz, Olga Shevetz, Marina Shtreiter, Shulamit Greenberg, Orly Mordich, Orna Amram, Inbal Binsky‐Ehrenreich, Ayelet Marom, Idit Shachar, Yair Herishanu, Rosa Ruchlemer, Alain Berrebi, Liora Valinsky, Mordechai Shtalrid, Lev Shvidel

Institutions: Kaplan Medical Center, Western Galilee Hospital, Weizmann Institute of Science, Tel Aviv University, Tel Aviv Sourasky Medical Center, Shaare Zedek Medical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Israel Cancer Association

OpenAlex ID: W2610674697

FWCI: 0.924

Cites: 10

Cited by: 32

Related to: 10